Log inSign up
Pharma-Marketing.comPharma-Marketing.com
  • Industry
  • Digital Health & AI
  • Channels
  • People
  • Agencies
  • Glossary
Log inSign up
  • Terms of Service
  • Privacy Policy
  • Cookie settings
  • Imprint
Pharma-Marketing.com


All rights reserved.

We use AI tools in the creation of certain content.

Pharma Marketing

Data-privacy settings

We use cookies to improve our website and services. They help us understand how visitors use our website. Some cookies are required for the website to function. These are marked as “essential” in the details.

AcceptEssential cookie
NameData-privacy settings
ProviderPharma-Marketing.com
PurposeStores these privacy settings in your browser.
Privacy policyPrivacy policy
Cookiespm_data_privacy
Cookie expiration180 days
Accept
NameGoogle Analytics
ProviderGoogle LLC
PurposeCookies by Google are used for website analytics. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_ga, _gat, _gid
Cookie expiration2 Years
Accept
NameGoogle Ads
ProviderGoogle LLC
PurposeCookies by Google Ads are used for advertising and targeting purpose.
Privacy policyPrivacy policy
Cookies__gsas, __gpi, __gpi_optout, NID, DSID, test_cookie, id, __gads
Cookie expiration2 Years
Accept
NameFacebook
ProviderFacebook Inc.
PurposeCookies by Facebook are used for advertising and marketing activities. Generates statistical data on how the visitor uses the website.
Privacy policyPrivacy policy
Cookies_fbp, fr
Cookie expiration2 Years
Accept
NameMicrosoft Clarity
ProviderMicrosoft Corporation
PurposeCookies by Microsoft Clarity are used for website analytics, heatmaps, and session recordings. They help us understand how visitors interact with our website so we can improve usability and performance.
Privacy policyPrivacy policy
Cookies_clck, _clsk, CLID, ANONCHK, MR, MUID, SM
Cookie expirationUp to 1 Year
© Image: Johnson & Johnson

Thursday, August 20, 2026

Johnson & Johnson publishes report on surgical intelligence

Johnson & Johnson has released a new Future of Digital Surgery report examining the emergence of surgical intelligence. The report, titled Surgery’s Next Inflection Point: The Rise of Surgical Intelligence, sets out how connected data, artificial intelligence and intelligent systems could influence the next phase of surgery.

Announced in New Brunswick on August 18, 2026, the publication aims to provide a common framework for a field that is still taking shape. Johnson & Johnson says the framework is intended to help healthcare stakeholders define, implement and scale surgical intelligence responsibly.

Operating room data in focus

The report points to the modern operating room as a data-rich environment, with information generated across multiple devices, applications and care settings. Much of that data remains separated across systems and institutions, limiting its value beyond individual procedures.

Johnson & Johnson links this challenge to broader pressures on healthcare systems, including workforce shortages, rising procedural complexity and financial constraints. The company argues that AI, connected technologies and advanced computing could help turn surgical data into clinical insight that improves over time.

A definition across the perioperative pathway

In the report, surgical intelligence is described as clinical knowledge created by connecting and analyzing multimodal data across the perioperative pathway. This includes preoperative planning, intraoperative execution and postoperative recovery.

The goal is to generate insights that support clinical decision making and improve operational performance. The report also stresses that the path forward is not only technical. It identifies governance, interoperability, sustainable economics and clinician-centered adoption as essential conditions for scale.

Input from healthcare and technology leaders

According to Johnson & Johnson, the report is based on interviews with more than 40 senior leaders from the surgical ecosystem. Participants included clinicians, providers, technology leaders, policymakers, investors and payers. The authors also reviewed more than 100 academic, clinical and industry publications.

Shan Jegatheeswaran, President of Polyphonic, MedTech, Johnson & Johnson, framed the topic as an ecosystem challenge. He emphasized that the future of surgery will depend not only on technological progress, but also on the ability to connect data, insights and people across care environments.

Call for coordinated action

The report calls on healthcare providers, clinical communities, industry and government to work together on the foundations needed for responsible innovation. Johnson & Johnson argues that decisions being made now on data sharing, governance, economics and adoption will influence how widely the benefits of surgical intelligence can be accessed.

For medtech and healthcare organizations, the publication adds to the growing debate over how digital surgery will move from isolated tools toward more integrated, data-driven systems.

Advertisement

Only a few physicians log in to your website?

Advertisement

A login that sets a new standard for authenticating HCPs and equips your marketing team with everything they need to successfully promote Rx-products. Learn more on DocID.pro


Stay up to date!

Subscribe to our free Pharma-Marketing-Newsletter.


A Partner For Successful Marketing in Pharma & Healthcare

Advertisement

8awake, the specialized agency for pharma and healthcare marketing, supports you with the successful development and execution of winning campaign activities in healthcare.

Leading providers in pharma and healthcare marketing

Sponsored
  • 8awake
  • MINTT Digital
  • 8awake

    The leading Healthcare & Pharma-Marketing-Agency

  • MINTT Digital

Looking for a new partner in pharma and healthcare marketing?

Visit our agency finder

Copyright 2026 Pharma-Marketing.com.